Work

Combination therapy with lenvatinib and anti-PD-1 antibodies for unresectable or advanced hepatocellular carcinoma: A real-world study.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e16610

Authors: Hui-Chuan Sun, Xiao-Dong Zhu, Cheng Huang, Ying-Hao Shen, Ning-Ling Ge, Yi Chen, Chang-Jun Tan, Jian Zhou, Jia Fan

Institutions: Fudan University, Zhongshan Hospital

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3032307940

Cites:

Cited by: 8

Related to: 10